genderaffirming

President Trump’s goal of ending gender-affirming care is not improper and cannot be the basis for quashing a subpoena issued by the Justice Department against a provider of medical treatment for transgender youth, a divided federal appeals court ruled Friday.

The Justice Department announced last year that it had issued more than 20 subpoenas to doctors and clinics that provide gender-affirming care as part of an effort to investigate healthcare fraud. Federal judges have quashed many of the subpoenas as illegitimate efforts to intimidate providers into ending care.

In a 2-1 decision, a panel of the 9th U.S. Circuit Court of Appeals said the efficacy and long-term risks of the treatments are “uncertain,” and the president has the power to align the Justice Department’s enforcement priorities with his broader policy goals.

“Every President has law enforcement priorities, just as every President has signature policies (often, the former are components of the latter),” wrote Judge Carlos Bea.

Bea, a nominee of Republican President George W. Bush, was joined in the opinion by Daniel Bress, a Trump nominee. They reversed a ruling that quashed the subpoena against telemedicine provider QueerDoc, sending the case back to the district court to consider other arguments.

The subpoena seeks QueerDoc’s personnel files, billing documents, communications with drug manufacturers and records of patients who were prescribed puberty blockers or hormone therapy, among other information, according to the 9th Circuit decision.

American Civil Liberties Union attorney Adrien Leavitt, who represented Washington state-based QueerDoc, said the ACLU would continue fighting the subpoena in district court. QueerDoc has also argued the subpoena is overbroad and burdensome. The Justice Department has said it has reason to believe the company may be misleading people about puberty blockers and hormones.

“We’re ready to continue defending one of the most fundamental principles of healthcare: every patient’s right to confidential medical care,” Leavitt said in a statement.

He said the San Francisco-based 9th Circuit was the first appeals court to weigh in on the subpoenas.

Trump has signed one executive order defining sex as only male or female — and as unchangeable — and another that seeks to end federal funding of the care for patients under 19. The latter order also directs the Justice Department to “prioritize investigations” into violations of a drug safety law by “any entity that may be misleading the public about long-term side effects of chemical and surgical mutilation.”

Gender-affirming care includes a range of medical and mental health services to support a person’s gender identity, including when it’s different from the sex they were assigned at birth. It encompasses counseling, medications that block puberty and hormone therapy to produce physical changes as well as surgeries to transform chests and genitals, though those are rare for minors.

Most major medical groups say access to the treatment is important for those with gender dysphoria and see gender as existing along a spectrum.

The 9th Circuit majority called discussion around gender-affirming care “an unsettled scientific debate” and said the Trump administration could also justify its opposition to the treatment on ethical or philosophical grounds.

Thanawala writes for the Associated Press.

Aug. 5 (UPI) — The Justice Department announced Wednesday that Connecticut Children’s Medical Center has agreed to stop offering gender-affirming care to minors amid the Trump administration’s crackdown on treatment supported by every major U.S. medical organization.

The Justice Department has been investigating doctors and clinics providing gender-affirming care to minors nationwide since at least July 2025, when it announced that the department had issued more than 20 subpoenas. The investigation followed a President Donald Trump executive order directing the department to prioritize investigations into alleged fraud, consumer deception and federal drug-law violations involving such care.

The order separately directed federal agencies to take steps to ensure that medical institutions receiving federal research or education grants end such care for people under 19.

The Justice Department did not identify the statutes or specify what federal laws Connecticut Children’s allegedly violated, but said Connecticut Children’s denies claims.

The Justice Department added that there was no determination of liability.

In the agreement announced Wednesday, which resolves the Justice Department’s allegations, Connecticut Children’s also agreed to pay an undisclosed monetary penalty and dedicate an additional $500,000 in medical care for individuals “living with the harmful consequences of ‘gender-affirming care,'” the Justice Department said.

UPI has contacted Connecticut Children’s for comment.

Gender-affirming care, including for minors, is supported by every major medical association in the United States. It includes a range of therapies, including psychological, behavioral and medical interventions, with surgeries for minors being exceedingly rare. According to a 2024 Harvard study, cisgender minors and adults were far more likely to undergo analogous gender-affirming surgeries than their transgender counterparts.

Contrary to medical guidance, Republicans over the past few years have sought to restrict and ban gender-affirming care, while spreading misinformation concerning such treatment.

Upon returning to the White House, Trump implemented a series of policies targeting transgender Americans, including issuing an executive order on his first day in office directing government policy to recognize only male and female as sexes and stating that they are “not changeable.”

Eight days later, he signed a second executive order, “Protecting Children From Chemical and Surgical Mutilation,” directing federal agencies to withhold funds from medical providers that offer gender-affirming medical care, such as puberty suppressants and hormones, to anyone under the age of 19.

In December, the Department of Health and Human Services announced proposed rules that would ban hospitals from performing gender-affirming care on minors as a condition of participating in Medicare and Medicaid programs.

The Connecticut Children’s agreement follows similar agreements reached by Texas Children’s and Cleveland Clinic with the Justice Department to stop providing gender-affirming care to minors.